Insider · CIK 0001486429

Ezickson Elan

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001486429

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-11	MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−2,300 sh	$0.55	−$1,265	0
2025-02-11	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.5K sh	—	—	0
2025-02-11	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.9K sh	—	—	0
2025-02-11	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.2K sh	—	—	0
2025-02-11	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.4K sh	—	—	0
2025-02-11	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16.5K sh	—	—	0
2025-02-11	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2025-02-07	MARINUS PHARMACEUTICALS, INC.D Disposition to Issuer	Director	DDisposition to Issuer	−8,600 sh	$0.55	−$4,730	2,300
2025-01-21	MARINUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,600 sh	$0.54	−$864	10,900
2024-06-18	MARINUS PHARMACEUTICALS, INC.A Award	Director	AAward	+2,300 sh	—	—	12,500
2024-06-18	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,450
2024-01-18	MARINUS PHARMACEUTICALS, INC.A Award	Director	AAward	+4,600 sh	—	—	10,200
2024-01-18	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+20.9K sh	—	—	20,900
2023-02-06	MARINUS PHARMACEUTICALS, INC.S Sale	Director	SSale	−750 sh	$6.56	−$4,920	5,600
2023-01-26	MARINUS PHARMACEUTICALS, INC.A Award	Director	AAward	+3,600 sh	—	—	6,350
2023-01-26	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+16.2K sh	—	—	16,200
2022-02-04	MARINUS PHARMACEUTICALS, INC.A Award	Director	AAward	+2,750 sh	—	—	2,750
2022-02-04	MARINUS PHARMACEUTICALS, INC.Stock Option (Right to Buy)A Award	Director	AAward	+12.4K sh	—	—	12,375
2021-01-15	MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award	Director	AAward	+16.5K sh	—	—	16,500
2019-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+31.8K sh	—	—	111,994
2019-12-31	TCRTAlaunos Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−40.1K sh	$4.72	−$189K	71,887
2019-12-11	MARINUS PHARMACEUTICALS, INC.Stock option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2018-12-31	TCRTAlaunos Therapeutics, Inc.A Award	Director	AAward	+80.2K sh	—	—	80,214
2018-09-18	TCRTAlaunos Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2018-05-29	SRRKScholar Rock Holding Corp · Stock Option (Right to Buy)A Award	COO & Head of Corp.Development	AAward	+8,757 sh	—	—	8,757
2013-01-28	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−1,150 sh	$7.77	−$8,936.765	61,843
2013-01-24	AVEO PHARMACEUTICALS, INC.A Award	Chief Operating Officer	AAward	+37.5K sh	—	—	62,993
2013-01-24	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Chief Operating Officer	AAward	+37.5K sh	—	—	37,500
2012-01-31	AVEO PHARMACEUTICALS, INC.A Award	Chief Operating Officer	AAward	+20.6K sh	—	—	25,493
2012-01-31	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)A Award	Chief Operating Officer	AAward	+35.1K sh	—	—	35,100
2012-01-26	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−1,107 sh	$13.37	−$14.8K	4,893
2011-06-10	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−10K sh	$18.73	−$187K	6,000
2011-05-16	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−10K sh	$18.08	−$181K	16,000
2011-04-11	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−10K sh	$13.63	−$136K	26,000
2011-03-16	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−7,500 sh	$14.42	−$108K	36,000
2011-02-22	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$1.32	+$6,600	16,000
2011-02-22	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−5,000 sh	$13.85	−$69.3K	11,000
2011-02-22	AVEO PHARMACEUTICALS, INC.Stock Option (right-to-buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	37,500
2011-02-15	AVEO PHARMACEUTICALS, INC.A Award	Chief Operating Officer	AAward	+6,000 sh	—	—	11,000
2011-02-15	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+16.3K sh	—	—	16,250
2011-02-15	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+17.5K sh	—	—	17,500
2011-01-10	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+5,000 sh	$1.32	+$6,600	5,000
2011-01-10	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−5,000 sh	$14.77	−$73.9K	5,000
2011-01-10	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−5,000 sh	—	—	42,500
2010-12-10	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−2,500 sh	$14.28	−$35.7K	37,500
2010-12-10	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−2,500 sh	$14.28	−$35.7K	37,500
2010-12-10	AVEO PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	+2,500 sh	$1.32	+$3,300	2,500
2010-12-10	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−2,500 sh	$14.28	−$35.7K	0
2010-12-10	AVEO PHARMACEUTICALS, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Operating Officer	MExercise/Conversion	−2,500 sh	—	—	47,500
2010-11-10	AVEO PHARMACEUTICALS, INC.S Sale	Chief Operating Officer	SSale	−5,000 sh	$16.33	−$81.6K	40,000

Recent filings

Accepted (ET)
Feb 114
Ezickson Elan0001104659-25-011248
SEC(opens sec.gov)
Jan 234
Ezickson Elan0001415889-25-001930
SEC(opens sec.gov)
Jun 204
Ezickson Elan0001415889-24-017634
SEC(opens sec.gov)
Jan 194
Ezickson Elan0001415889-24-001600
SEC(opens sec.gov)
Feb 84
Ezickson Elan0001415889-23-002162
SEC(opens sec.gov)
Jan 304
Ezickson Elan0001415889-23-001560
SEC(opens sec.gov)
Feb 74
Ezickson Elan0001104659-22-012783
SEC(opens sec.gov)
Jan 194
Ezickson Elan0001104659-21-005519
SEC(opens sec.gov)
Jan 34
Ezickson Elan0001209191-20-001171
SEC(opens sec.gov)

Companies

Address

C/O AVEO PHARMACEUTICALS, INC. 75 SIDNEY STREET

CAMBRIDGE, MA, 02139